Clinical Trials Logo

Osteogenesis Imperfecta Type II clinical trials

View clinical trials related to Osteogenesis Imperfecta Type II.

Filter by:
  • None
  • Page 1

NCT ID: NCT01061099 Completed - Clinical trials for Osteogenesis Imperfecta Type III

Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta

STOD3
Start date: February 2010
Phase: Phase 1
Study type: Interventional

This is a study to evaluate the safety and effectiveness of repeated Mesenchymal Stromal Cells (MSC) infusions to patients with Type II or III osteogenesis imperfecta (OI). Participants will receive MSC infusions approximately every 4 months to complete a total of 6 infusions over 20 months. Participants will be followed for 4 months post their last MSC infusion.